TY - CHAP
T1 - Resuscitation of 'uncultured' microorganisms
AU - Goodacre, Royston
AU - Mukamolova, Galina V.
AU - Young, Michael
AU - Kaprelyants, Arseny S.
AU - Zhao, Hongjuan J.
AU - Kell, Douglas B.
AU - Finan, Christopher L.
N1 - Kell, D. B., Mukamolova, G. V., Finan, C. L., Zhao, H., Goodacre, R., Kaprelyants, A. S., Young, M. (2004). Resuscitation of 'uncultured' microorganisms. In, Microbial Biodiversity and Bioprospecting, Bull, A.T. (ed). ISBN:9781555812676, pp. 100-108
Key Features:
-Unique and comprehensive synthesis of biotechnology search and discovery in the post-genomic area.
-Reveals the extraordinary scale of microbial diversity and how technologies enable it to be estimated, defined, and exploited.
-Discusses the application of microbiology to a wide range of industrial sectors.
-World leaders in their respective fields present state-of-the-art material.
PY - 2004
Y1 - 2004
N2 - As the title implies, this book is about microbes and their value
in bioprospecting, but this book will be of great value to anyone
toiling with any source of natural products as leads to drugs,
agrochemicals, or other agents of use to mankind. The editor
assembled a panel of experts across numerous microbiology
specialties and, together, they produced this exceptionally well
written treatise on the critical issues that confront those bioprospecting
the microbial riches of the world.
After a brief introduction on the rationale for exploring and
exploiting biological diversity, the book is divided into eight
substantive sections or topic areas: Microbial Diversitysthe
Resource; Microbial Ecologysthe Key to Discovery; Biogeography
and Mapping Microbial Diversity; Bioinformatics; Prospectingsthe
Targets; Conservation of Microbial Gene Pools; and Convention
on Biological DiversitysImplications for Microbial Prospecting.
The book then concludes with a brief chapter on the value of
biodiversity, by an economist, with various economic formulas and
calculations.
This reviewer could find but one mistake in the text, and it had
nothing to do with microbiology. Chapter 39, on the convention
on biodiversity and benefit sharing, discusses an agreement between
an Australian pharmaceutical company, AMRAD, and the Western
Australian Department of Conservation and Land Management,
CALM, to access and commercialize compounds from a species
of smokebush, Conospermum, and refers to the active agent as an
antitumor compound. The pharmacological activity in question was
actually anti-HIV activity.
While the book is well indexed and numerous references are
provided in each of the 44 chapters, the book is not intended as a
comprehensive review, but rather a philosophical overview with a
sense of the state of the science in each of the technical areas. There
is something for everyone in this book, from advanced undergraduate
to long-time veteran principal investigators. The text is thoughtprovoking,
as much as it is informative. This book is heartily
recommended to any individual who can afford it and to all
institutional libraries, academic, government, and industrial.
AB - As the title implies, this book is about microbes and their value
in bioprospecting, but this book will be of great value to anyone
toiling with any source of natural products as leads to drugs,
agrochemicals, or other agents of use to mankind. The editor
assembled a panel of experts across numerous microbiology
specialties and, together, they produced this exceptionally well
written treatise on the critical issues that confront those bioprospecting
the microbial riches of the world.
After a brief introduction on the rationale for exploring and
exploiting biological diversity, the book is divided into eight
substantive sections or topic areas: Microbial Diversitysthe
Resource; Microbial Ecologysthe Key to Discovery; Biogeography
and Mapping Microbial Diversity; Bioinformatics; Prospectingsthe
Targets; Conservation of Microbial Gene Pools; and Convention
on Biological DiversitysImplications for Microbial Prospecting.
The book then concludes with a brief chapter on the value of
biodiversity, by an economist, with various economic formulas and
calculations.
This reviewer could find but one mistake in the text, and it had
nothing to do with microbiology. Chapter 39, on the convention
on biodiversity and benefit sharing, discusses an agreement between
an Australian pharmaceutical company, AMRAD, and the Western
Australian Department of Conservation and Land Management,
CALM, to access and commercialize compounds from a species
of smokebush, Conospermum, and refers to the active agent as an
antitumor compound. The pharmacological activity in question was
actually anti-HIV activity.
While the book is well indexed and numerous references are
provided in each of the 44 chapters, the book is not intended as a
comprehensive review, but rather a philosophical overview with a
sense of the state of the science in each of the technical areas. There
is something for everyone in this book, from advanced undergraduate
to long-time veteran principal investigators. The text is thoughtprovoking,
as much as it is informative. This book is heartily
recommended to any individual who can afford it and to all
institutional libraries, academic, government, and industrial.
M3 - Chapter
SN - 9.781555812676E12
SP - 100
EP - 108
BT - In
A2 - A, T.
PB - American Society for Microbiology
ER -